Relevant A&O/Shearman & Sterling and previous firm experience includes advising:

• Hikma Pharmaceuticals against "reverse payment" allegations relating to Jazz Pharmaceuticals' landmark drug, Xyrem.
• The National Association of REALTORS® coordinating defense of multiple antitrust litigations across the country.
• Avangrid in action challenging competitor’s tactics to delay major electricity project.
• Gerber in class action stemming from a Congressional report on presence of heavy metals in baby food.
• Avast on U.S. antitrust merger clearance for its USD9.2bn merger with Norton LifeLock.
• AbbVie against “reverse payment” allegations relating to drug Loestrin.
• Nestlé USA in action against hardware manufacturer to recover damages for anationwide cookie dough recall.
• Grupo Verzatec against antitrust challenges to a proposed merger.
• Pfizer in litigation challenging a competitor’s efforts to deter biosimilar competition to Remicade.
• Anthem against the U.S. Department of Justice's lawsuit to block its USD54.2bn acquisition of Cigna Corporation, the largest merger ever in the health insurance industry at the time.
• Boehringer Ingelheim against anticompetitive "reverse payment" allegations related to Aggrenox®.
• Clients on distribution pricing issues under the Robinson-Patman Act.
• Allergan/Warner Chilcott against claims challenging the transition to new versions of its Doryx® acne treatment.
• Former employee of a leading commodities broker in an alleged USD600mn fraud involving the valuation of natural gas options positions by a major Canadian bank.
• Pilot Travel Centers, Pilot Flying J, the largest US diesel retailer, in more than 20 putative class actions nationwide.